Mission: To help our clients realize their most important goals. And beyond.

Who we are

Dr Dragan Grabulovski, CEO and founder of Grabulovski Consulting Services

Grabulovski Consulting Services was founded by Dr Dragan Grabulovski. Dragan has more than 10 years of experience in the pharmaceutical biotechnology field. He was the Chief Scientific Officer (CSO) and co-founder of Covagen, a Swiss biotechnology company acquired by Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson (press release).

Dragan’s main professional qualifications and key achievements are the following:

  • Trade sale of Covagen to Johnson & Johnson
  • Closing deals with major pharmaceutical companies including collaboration agreements between Covagen and Roche (Switzerland) and between Covagen and Mitsubishi Tanabe Pharma Corporation (Japan) / Tanabe Research Laboratories (USA)
  • Elaboration and implementation of Covagen’s R&D strategy
  • Responsibility in fund raising activities (Covagen raised > CHF 50 million of venture capital between 2007 and 2014)
  • Leading discovery research groups and scientific staff (> 20 employees)
  • Establishing a large network with Key Opinion Leaders (KOLs), scientific institutions, venture capitalists, patent attorneys and industrial managers
  • Data review including quality assurance
  • Start-up coach at ETH Zurich and CTI, the Swiss Commission for Technology and Innovation          

Dragan Grabulovski obtained his PhD at ETH Zurich in the group of Prof Dario Neri. During his PhD studies he invented the Fynomer technology which was commercialized by CovagenPrior to that, he studied pharmaceutical sciences at ETH Zurich and for the diploma thesis under the supervision of Prof Gerd Folkers he was awarded with the ETH medal. He is a co-author of several peer-reviewed articles, reviews, book chapters, poster abstracts, patent applications and granted patents (publication list). He is also a jury member of „venture“, Switzerland’s premier start-up competition organized by McKinsey, CTI (Swiss commission for technology and innovation) and ETH Zurich.